Kitchen sponges have been shown to cultivate more bacteria than the traditional agar ... Klebsiella: An opportunistic pathogen resistant to many antibiotics, Klebsiella can lead to pneumonia ...

Instead, a LB agar medium was chosen to obtain microbial colonies ... A previous study [15] showed that Ralstonia sp. in combination with Klebsiella pneumoniae were able to utilize Figure 3.

Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...

Klebsiella pneumoniae, a dangerous bacterium responsible for pneumonia, has been discovered in Ukraine. Experts are alarmed as the bacterium is resistant to drugs. Scientists believe it poses a ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

Discover how natural products like tea tree oil and apple cider vinegar show promise in fighting multidrug-resistant ...

Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.

Pneumonia is a lung infection caused by bacteria, viruses, fungi, or tuberculosis. Symptoms include fever, cough, chest pain, and shortness of breath. Early diagnosis and treatment are crucial to ...